Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Oogenesis02:07

Oogenesis

63.7K
In human women, oogenesis produces one mature egg cell or ovum for every precursor cell that enters meiosis. This process differs in two unique ways from the equivalent procedure of spermatogenesis in males. First, meiotic divisions during oogenesis are asymmetric, meaning that a large oocyte (containing most of the cytoplasm) and minor polar body are produced as a result of meiosis I, and again following meiosis II. Since only oocytes will go on to form embryos if fertilized, this unequal...
63.7K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Disruption of microtubules with low intensity ultrasound rescues hair follicle damage by paclitaxel in mouse models.

Nature communications·2026
Same author

Poly(adenosine diphosphate-ribose) polymerase inhibitor maintenance therapy with niraparib in patients with primary advanced or recurrent endometrial cancer receiving dostarlimab plus chemotherapy.

International journal of gynecological cancer : official journal of the International Gynecological Cancer Society·2026
Same author

Corrigendum to "Joint GOG-Foundation (GOG) and European Network of Gynaecological Oncological Trial Groups (ENGOT) clinical trials guidance for operations with industry partners" [International Journal of Gynecological Cancer 36 (2026) 104753].

International journal of gynecological cancer : official journal of the International Gynecological Cancer Society·2026
Same author

A pilot translational study of neoadjuvant fulvestrant plus abemaciclib in women with advanced low-grade serous carcinoma.

Nature communications·2026
Same author

Allostatic Load in Endometrial Cancer Disparities.

medRxiv : the preprint server for health sciences·2026
Same author

Reconstruction of septin higher-order nano-size structures in ovarian cancer cells uncover susceptibility to the septin-targeting small molecule UR214-9.

bioRxiv : the preprint server for biology·2026

Related Experiment Video

Updated: Jul 6, 2025

Z-Scores for Assessing Ovarian Reserve in Young Patients Undergoing Fertility Preservation
05:42

Z-Scores for Assessing Ovarian Reserve in Young Patients Undergoing Fertility Preservation

Published on: October 25, 2024

1.2K

Normal Risk Ovarian Screening Study: 21-Year Update.

Chae Young Han1, Karen H Lu2, Gwen Corrigan1

  • 1Department of Experimental Therapeutics, University of Texas MD Anderson Cancer Center, Houston, TX.

Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|January 9, 2024
PubMed
Summary
This summary is machine-generated.

The Normal Risk Ovarian Screening Study (NROSS) used a two-stage strategy to detect ovarian cancer in postmenopausal women. This screening approach showed promise in identifying early-stage disease and reducing late-stage diagnoses.

More Related Videos

In Vivo and Ex Vivo Approaches to Study Ovarian Cancer Metastatic Colonization of Milky Spot Structures in Peritoneal Adipose
13:04

In Vivo and Ex Vivo Approaches to Study Ovarian Cancer Metastatic Colonization of Milky Spot Structures in Peritoneal Adipose

Published on: October 14, 2015

13.1K
Murine Model for Non-invasive Imaging to Detect and Monitor Ovarian Cancer Recurrence
08:55

Murine Model for Non-invasive Imaging to Detect and Monitor Ovarian Cancer Recurrence

Published on: November 2, 2014

12.3K

Related Experiment Videos

Last Updated: Jul 6, 2025

Z-Scores for Assessing Ovarian Reserve in Young Patients Undergoing Fertility Preservation
05:42

Z-Scores for Assessing Ovarian Reserve in Young Patients Undergoing Fertility Preservation

Published on: October 25, 2024

1.2K
In Vivo and Ex Vivo Approaches to Study Ovarian Cancer Metastatic Colonization of Milky Spot Structures in Peritoneal Adipose
13:04

In Vivo and Ex Vivo Approaches to Study Ovarian Cancer Metastatic Colonization of Milky Spot Structures in Peritoneal Adipose

Published on: October 14, 2015

13.1K
Murine Model for Non-invasive Imaging to Detect and Monitor Ovarian Cancer Recurrence
08:55

Murine Model for Non-invasive Imaging to Detect and Monitor Ovarian Cancer Recurrence

Published on: November 2, 2014

12.3K

Area of Science:

  • Gynecologic Oncology
  • Cancer Screening
  • Early Detection of Cancer

Background:

  • Ovarian cancer screening in postmenopausal women remains a challenge.
  • The Normal Risk Ovarian Screening Study (NROSS) investigated a novel two-stage screening approach.
  • Early detection is crucial for improving ovarian cancer patient outcomes.

Purpose of the Study:

  • To evaluate a two-stage ovarian cancer screening strategy in postmenopausal women at conventional hereditary risk.
  • To assess the efficacy of using rising cancer antigen (CA)-125 levels to prompt transvaginal sonography (TVS) and subsequent surgery.
  • To determine the sensitivity, specificity, and positive predictive value (PPV) of the NROSS screening protocol.

Main Methods:

  • A total of 7,856 healthy postmenopausal women were screened annually over 50,596 woman-years.
  • Serum CA-125 levels were analyzed using the Risk of Ovarian Cancer Algorithm (ROCA).
  • A rising ROCA score prompted TVS, with abnormal TVS leading to surgical referral.

Main Results:

  • The screening identified 15 ovarian cancers and two borderline tumors, with 12 cases diagnosed at early stages (I-II).
  • Seven endometrial cancers were also detected, with six in stage I.
  • The study demonstrated a 74% sensitivity for ovarian and borderline cancers and a significant reduction in late-stage disease compared to control groups.

Conclusions:

  • The NROSS screening strategy demonstrated high specificity and PPV, exceeding study endpoints.
  • The observed shift towards earlier stage diagnoses supports the further development of this ovarian cancer screening approach.
  • While not powered for mortality reduction, the findings suggest potential benefits for early ovarian cancer detection.